tiprankstipranks
Trending News
More News >
Clorox (CLX)
NYSE:CLX
US Market

Clorox (CLX) Earnings Dates, Call Summary & Reports

Compare
3,098 Followers

Earnings Data

Report Date
May 05, 2026
Before Open (Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
1.59
Last Year’s EPS
1.45
Same Quarter Last Year
Based on 15 Analysts Ratings

Earnings Call Summary

Q2 2026
Earnings Call Date:Feb 03, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call balanced clear execution progress (ERP completion, stronger digital/RGM capabilities, a robust back-half innovation slate, and strategic health/hygiene expansion) with near-term operational and category challenges (flat category growth, household pricing/volume weakness, elevated promotions, and ERP-related supply-chain noise). Management reaffirmed guidance, sees sequential improvement, and expects margin recovery in Q4, but meaningful recovery depends on innovation ramp and category demand. The positives and negatives were comparably weighted, with cautious optimism for the back half.
Company Guidance
Clorox reaffirmed its guidance and said it expects category growth of 0–1% in the back half after Q1–Q2 were roughly flat (Q2 about -0.1% ex‑beauty) with sequential improvement and recent share gains; Q2 included roughly 1 point of shipment favorability from ERP prebuild that should unwind in Q3, and ERP phasing results imply about a 3.5‑point sales pickup and ~$0.90 EPS benefit in the next fiscal year; the company is targeting advertising at ~11% of sales (H1 ~11.5%), sees ~1% full‑year price/mix headwind (household pricing was negative in Q2), reported Q2 EBIT margin of 5.3%, expects Q3 gross margin roughly flat and solid expansion in Q4 (including ~50 bps benefit from the Glad JV termination), and flagged roughly $0.08 of digital/ERP‑related adjustments in Q3 before anticipated automation, cost‑savings run‑rate gains and further margin improvement.
ERP Implementation Near Completion
Completed final phase of ERP in January; final-phase prebuild caused ~1 point shipment favorability in Q2 that is expected to reverse in Q3. Management expects remaining one-time digital/ERP adjustments (~$0.08 EPS in Q3) to finish and normalization benefits to contribute to FY27 (shipment normalization ~+3.5 points of sales and estimated EPS pickup ~+$0.90).
Back-half Innovation Pipeline and Increased Launch Investment
Heavy back-half product launches across major brands (new allergen-destroying cleaner, Glad Leakguard, litter relaunch, Hidden Valley avocado ranch, Glad four-flex expansion). Company doubled typical launch-size marketing investment for key launches and expects most shelf resets in late Q3 / early Q4.
Strategic Health & Hygiene Expansion (Gojo/Purell)
Planned acquisition of Gojo (Purell) expected to expand leadership in health & hygiene, be accretive to growth, and leverage Gojo's management/operations; management views this as a strong strategic fit to unlock long-term growth opportunities in pro and retail channels.
Digital & RGM Capabilities to Improve Pricing and Pack Architecture
ERP/data harmonization and increased Revenue Growth Management capabilities to enable better price/pack mix decisions at scale, faster responses to channel shifts (club/e‑comm/dollar), and improved ability to fund strategic price investments when necessary.
Gross Margin Outlook Improving in Back Half
After front-half contraction, management expects Q3 gross margin roughly flat and solid expansion in Q4 as incremental ERP-related logistics expenses decline and cost-savings ramp; Glad JV termination expected to add ~50 basis points of benefit in the back half.
Early Sequential Improvement and Positive January Signals
Company reported sequential improvement through Q2, noted January consumption pickup and share gains in the last week of January — management describes this as early momentum heading into back half.
Advertising & Demand Investment Discipline
Advertising targeted at ~11% of sales for the year (first half at ~11.5%); spending is being allocated at SBU level to balance advertising and trade to support launches and drive trial.

Clorox (CLX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CLX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 05, 2026
2026 (Q3)
1.59 / -
1.45
Feb 03, 2026
2026 (Q2)
1.43 / 1.39
1.55-10.32% (-0.16)
Nov 04, 2025
2026 (Q1)
0.78 / 0.85
1.86-54.30% (-1.01)
Jul 31, 2025
2025 (Q4)
2.20 / 2.87
1.8257.69% (+1.05)
May 05, 2025
2025 (Q3)
1.55 / 1.45
1.71-15.20% (-0.26)
Feb 03, 2025
2025 (Q2)
1.40 / 1.55
2.16-28.24% (-0.61)
Oct 30, 2024
2025 (Q1)
1.41 / 1.86
0.49279.59% (+1.37)
Aug 01, 2024
2024 (Q4)
1.55 / 1.82
1.678.98% (+0.15)
Apr 30, 2024
2024 (Q3)
1.36 / 1.71
1.5113.25% (+0.20)
Feb 01, 2024
2024 (Q2)
1.09 / 2.16
0.98120.41% (+1.18)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CLX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 03, 2026
$114.98$117.77+2.43%
Nov 04, 2025
$109.21$107.73-1.36%
Jul 31, 2025
$121.66$119.28-1.96%
May 05, 2025
$134.09$130.85-2.41%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Clorox (CLX) report earnings?
Clorox (CLX) is schdueled to report earning on May 05, 2026, Before Open (Confirmed).
    What is Clorox (CLX) earnings time?
    Clorox (CLX) earnings time is at May 05, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CLX EPS forecast?
          CLX EPS forecast for the fiscal quarter 2026 (Q3) is 1.59.

            Clorox (CLX) Earnings News

            Clorox (NYSE:CLX) Surges on Upbeat Q2 Earnings
            Premium
            Market News
            Clorox (NYSE:CLX) Surges on Upbeat Q2 Earnings
            2y ago
            Clorox Stock (NYSE:CLX) Jumps on Robust Outlook
            Premium
            Market News
            Clorox Stock (NYSE:CLX) Jumps on Robust Outlook
            3y ago
            Clorox Stock Falls on an Unimpressive Q4 Show, Dismal Guidance
            Premium
            Market News
            Clorox Stock Falls on an Unimpressive Q4 Show, Dismal Guidance
            4y ago